These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11155224)

  • 1. Antipsychotic drug-induced hyperprolactinemia: clinical implications.
    Molitch ME
    Endocr Pract; 2000; 6(6):479-81. PubMed ID: 11155224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone].
    Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM
    An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
    Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
    J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Galactorrhea and secondary amenorrhea in hyperprolactinemia].
    Wallmeroth A; Staub JJ
    Praxis (Bern 1994); 2000 Aug; 89(34):1341-3. PubMed ID: 11021189
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone in children with autism and serious behavioral problems.
    Valiquette G
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071
    [No Abstract]   [Full Text] [Related]  

  • 7. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
    Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
    Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone-induced hyperprolactinemia in an elderly woman.
    Bai YM; Ciu HJ; Guo ZZ
    Am J Psychiatry; 2002 Dec; 159(12):2112. PubMed ID: 12450970
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M; Bares M; Horacek J; Mohr P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
    J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia.
    Lin CH; Hsu CW; Tsao TY; Chou J
    Diagn Pathol; 2012 Jan; 7():2. PubMed ID: 22221904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia induced by antipsychotic agents].
    Johnsen E; Jørgensen HA
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):179-80. PubMed ID: 16415943
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole.
    Mazher OA; Maneta E; Hall W
    J Clin Psychopharmacol; 2018 Oct; 38(5):529-531. PubMed ID: 30106879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.